Selectivity in Cancer Chemotherapy
Over the past thirty years a large number of chemicals of different structures have been found to inhibit the growth of animal tumours. A small number of these have subsequently been used with usually limited success in the treatment of a few types of human cancer. Anticancer agents have been discovered by ‘screening’ usually against transplanted rodent tumours, by a study of analogues of known active compounds or by the rational design of chemicals based on a knowledge of the biochemistry of a particular cancer.
KeywordsCancer Chemotherapy Cytosine Arabinoside Clara Cell Nitrogen Mustard Carrier Molecule
Unable to display preview. Download preview PDF.
- 2.R.H. Blum and E. Frei, III. Comination chemotherapy, Methods in Cancer Research, XVII: 215 (1979).Google Scholar
- 4.T. Johima, M. Hashida, S. Muranishi and H. Sezaki, Mitomycin C-dextran conjugate: a novel high molecular weight prodrug of mitomycin C, J. Pharm. Pharmacol. 32: 30 (1980).Google Scholar
- 5.F.M. Sirotnak, P.L. Chellow and R.W. Brockman, Potential for exploitation of transport systems in anticancer drug design, Methods in Cancer Research, XVl: 381 (1979).Google Scholar
- 9.M.M. Manson, R.F. Legg, J.V. Watson, J.A. Green and G.E. Neal, An examination of the relative resistances to aflatoxin B and susceptibilities to y-glutamyl-p-phenylene diamine mustard of p-glutamyl transferase negative and positive cell lines, Carcinogenesis 2: 661 (1981).PubMedCrossRefGoogle Scholar
- 17.D.S. Zaharko, M. Przybylski and V.T. Oliverio, Binding of anticancer drugs to carrier molecules, Methods in Cancer Research XVI: 347 (1979).Google Scholar